These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33377132)

  • 1. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.
    Jiang S; Zhao H; Zhang W; Wang J; Liu Y; Cao Y; Zheng H; Hu Z; Wang S; Zhu Y; Wang W; Cui S; Lobie PE; Huang L; Ma S
    Cell Rep Med; 2020 Dec; 1(9):100161. PubMed ID: 33377132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic droplet encapsulation-guided organoid growth promotes parental tumor phenotype recapitulation.
    Zhang W; Jin H; Lou S; Yang H; Dai X; Ma S
    Int J Cancer; 2024 Jan; 154(1):145-154. PubMed ID: 37622267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automation of Organoid Cultures: Current Protocols and Applications.
    Louey A; Hernández D; Pébay A; Daniszewski M
    SLAS Discov; 2021 Oct; 26(9):1138-1147. PubMed ID: 34167363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
    Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
    Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.
    Phan N; Hong JJ; Tofig B; Mapua M; Elashoff D; Moatamed NA; Huang J; Memarzadeh S; Damoiseaux R; Soragni A
    Commun Biol; 2019; 2():78. PubMed ID: 30820473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Specific Microfluidic Cancer Spheroid Cultures for Testing Cancer Therapies.
    Choi D; Gonzalez-Suarez AM; Billadeau DD; Ma WW; Stybayeva G; Revzin A
    Methods Mol Biol; 2023; 2679():219-231. PubMed ID: 37300619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
    Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
    Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards Automation in 3D Cell Culture: Selective and Gentle High-Throughput Handling of Spheroids and Organoids via Novel Pick-Flow-Drop Principle.
    Zieger V; Frejek D; Zimmermann S; Miotto GAA; Koltay P; Zengerle R; Kartmann S
    Adv Healthc Mater; 2024 Apr; 13(9):e2303350. PubMed ID: 38265410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
    Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
    J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
    Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
    Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation cancer organoids.
    LeSavage BL; Suhar RA; Broguiere N; Lutolf MP; Heilshorn SC
    Nat Mater; 2022 Feb; 21(2):143-159. PubMed ID: 34385685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Cancer Medicine: An Organoid Approach.
    Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
    Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
    Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
    Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.
    Votanopoulos KI; Forsythe S; Sivakumar H; Mazzocchi A; Aleman J; Miller L; Levine E; Triozzi P; Skardal A
    Ann Surg Oncol; 2020 Jun; 27(6):1956-1967. PubMed ID: 31858299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pan-cancer organoid platform for precision medicine.
    Larsen BM; Kannan M; Langer LF; Leibowitz BD; Bentaieb A; Cancino A; Dolgalev I; Drummond BE; Dry JR; Ho CS; Khullar G; Krantz BA; Mapes B; McKinnon KE; Metti J; Perera JF; Rand TA; Sanchez-Freire V; Shaxted JM; Stein MM; Streit MA; Tan YC; Zhang Y; Zhao E; Venkataraman J; Stumpe MC; Borgia JA; Masood A; Catenacci DVT; Mathews JV; Gursel DB; Wei JJ; Welling TH; Simeone DM; White KP; Khan AA; Igartua C; Salahudeen AA
    Cell Rep; 2021 Jul; 36(4):109429. PubMed ID: 34320344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.